The Dime Bryan Fields & Kellan Finney

The 2018 Farm Bill has undeniably reshaped the cannabis industry, blurring lines and unlocking opportunities between hemp and cannabis. This episode delves into the nuanced differences and similarities between these two facets of the cannabis world. Chris Fontes shares his insights to dissect the complex web of legislation, the evolving roles of MSOs and Big Pharma, and the boundless opportunities emerging from regulatory challenges. Discover how today's cannabis entrepreneurs are utilizing the interpretation of opportunities to transform obstacles into avenues for innovation and sector growth.

This week, we sit down with Chris Fontes to discuss the following:

Hemp vs. Cannabis: Exploring Opportunities, Differences, and Challenges.
Impact of the 2018 Farm Bill: What's next for legislation and how it shapes the industry.
MSOs, Big Pharma's influence, and more.

About Chris Fontes:

Chris Fontes, the Founder and CEO of High Spirits Beverages, is a dynamic individual with a rich history of innovation and leadership in the cannabis industry and beyond. His entrepreneurial journey spans several successful ventures, including Trojan Horse Cannabis, Project Hemp Flower, and Hemp Exchange, all of which played pivotal roles in shaping the US hemp industry. Chris's visionary leadership led to the development of the industry's first hemp-derived D9 THC products and the launch of Trojan Horse Cannabis and High Spirits Beverages.



Guest Links:

https://www.linkedin.com/in/chrisfontes/
https://highspiritsbeverages.com/
https://trojanhorsecannabis.com/
Facebook: HighSpiritsBeverage
LinkedIn: High Spirits Bev
X (Twitter): @HighSpiritsBevs

Follow us: Our Links.

At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.

8th Revolution Cannabinoid Playbook is an Industry-leading report covering the entire cannabis supply chain

The Dime is a top 5% most shared global podcast

The Dime is a top 50 Cannabis Podcast

Sign up for our playbook here:

🎥 YouTube:  The Dime

📸 Instagram:  The Dime

Capital in the cannabis industry is not just scarce; it's a puzzle.

Have you come across terms like sale-leaseback and triple net lease in press releases and earnings reports yet find yourself questioning their actual mechanics?

What's more, the implications for companies opting for these leasebacks might be more surprising than you think.

And from the perspective of a REIT company, how do they pinpoint opportunities, especially when evaluating location and market potential?

These insights are valuable for understanding the framework for decision-making, both short and long-term.

This week, we sit down with Anthony Coniglio to discuss the following:

What are a sale-leaseback and a triple net lease?
Portfolio diversification, tenant quality, and location choice.
Strategies for injecting capital into cannabis companies.



Guest Links:

https://www.linkedin.com/in/coniglioanthony/
https://www.newlake.com/
https://twitter.com/NewLakeCapital
https://www.linkedin.com/company/newlake/
https://twitter.com/NewLakeCapital
https://twitter.com/AnthonyConigli0



Follow us: Our Links.

At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.

8th Revolution Cannabinoid Playbook is an Industry-leading report covering the entire cannabis supply chain

The Dime is a top 5% most shared global podcast

The Dime is a top 50 Cannabis Podcast

Sign up for our playbook here:

🎥 YouTube:  The Dime

📸 Instagram:  The Dime

Major industry behemoths like P&G or British Tobacco are setting their sights on the cannabis industry, poised to disrupt and seamlessly integrate.

In this rapidly evolving landscape, are you engaging in crucial internal and external conversations in anticipation of the next wave?

This week, we sit down with Seth Yakatan to discuss the following:

Founders and Companies set up for major exits.
Secrets to a Profitable, Cash-Flowing Operation
Build to Sell vs Build to Compete
How CPG giants are eyeing cannabis for potential mergers.



Guest Links

Katan Associates International | Corporate Strategy & Merchant Banking | United States

https://www.linkedin.com/company/katan-associates-international/

https://www.linkedin.com/in/seth-yakatan/

Follow us: Our Links.

At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.

8th Revolution Cannabinoid Playbook is an Industry-leading report covering the entire cannabis supply chain

The Dime is a top 5% most shared global podcast

The Dime is a top 50 Cannabis Podcast

Sign up for our playbook here:

🎥 YouTube:  The Dime

📸 Instagram:  The Dime

Amidst the breaking down the walls of prohibition, it's clear that change is underway. The speed at which the cannabis industry is evolving is hard to truly grasp unless you step back and appreciate how much has altered in the last 10 years compared to the previous 100.

While issues and unknowns persist, incremental progress with accelerated catalysts is gaining momentum, making one thing extremely clear:

The genie is unlikely to go back into the bottle.

This week, we sit down to reflect on the past with an understanding of what lies ahead.

Todd Harrison joins us to discuss the following:

Economic Opportunity
Catalysts S3, Safer, Election, States
Under Recognized Cannabinoids Medical Benefits
And so much more



Guest Links

https://toddharrison.substack.com/
https://www.cb1cap.com/
https://twitter.com/CB1Cap
https://twitter.com/todd\_harrison

About CB1 Capital

We believe the cannabis plant has untapped efficacious agility and will disrupt Western medicine; and we believe medical breakthroughs will soon shatter conventional wisdom.Integrity matters; CB1 Capital was built with the foundational constructs of honesty, trust and respect and our partners, employees and advisors are held to the highest standard of conduct and operational diligence.This platform was set up to educate and inform; we believe this is the next generation of impact investing and our mission is to effect positive change through cannabinoid wellness.

About Todd Harrison:

Todd Harrison is the Founding Partner / Chief Investment Officer of CB1 Capital Management. Todd has spent over three decades on Wall Street managing risk and researching financial market strategies. His institutional experience includes Morgan Stanley Equity Derivatives (VP), The Galleon Group (MD), and Cramer, Berkowitz LLC (President / Head of Trading)

Follow us: Our Links.

At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.

8th Revolution Cannabinoid Playbook is an Industry-leading report covering the entire cannabis supply chain

The Dime is a top 5% most shared global podcast

The Dime is a top 50 Cannabis Podcast

Sign up for our playbook here:

🎥 YouTube:  The Dime

📸 Instagram:  The Dime

"Great companies were never built by conservative leaders.

Great companies were built by risk-takers."

Deeply ingrained in Curaleaf's DNA is the ability to navigate the unknown ahead of opportunities.

Timing these events is nearly impossible, but having the foresight and strategic resources in place when the opportunity strikes can change the game.

For visionaries like Boris Jordan, being early in markets like Germany can be challenging for everyone to see until recent developments materialize.

The US and European cannabis markets operate very differently, and Curaleaf is in a prime position to secure an untapped market share twice the size of the US.

This week, we sit down with Boris Jordan to discuss the following:

Unique Market Differences: Europe vs US
Educating Institutional Investors: What does that conversation look like inside the room?
Breakdown of the German Market, Hint toward Asia
And so much more



About Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, and Grassroots provide industry-leading service, product selection and accessibility across the medical and adult use markets. In the United States, our brands are sold in 17 states with operations encompassing 147 dispensaries and employing more than 5,200 team members. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Toronto Stock Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF.



Follow us: Our Links.

At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.

8th Revolution Cannabinoid Playbook is an Industry-leading report covering the entire cannabis supply chain

The Dime is a top 5% most shared global podcast

The Dime is a top 50 Cannabis Podcast

Sign up for our playbook here:

🎥 YouTube:  The Dime

📸 Instagram:  The Dime

Investing in cannabis stocks is not for the faint of heart. It's common to see these stocks pop only to retrace their gains quickly.

Understanding the implications and the strategies that institutional investors will use as they enter the sector, currently dominated by retail, could be a generational difference-maker for so many.

This week, we speak with Pablo Zuanic to discuss the following:

Cannabis Long-Term Investments:
Navigating Market Nuances 
280E Removal, Germany implications 
So much more 

About Pablo Zuanic 

Pablo Zuanic is a well-known and highly rated consumer sector equity analyst, most recently following the cannabis and psychedelics sector. Over the past four years he launched coverage of over 35 companies (MSOs, LPs, CBD, MJ ancillary, mental health clinics), kept close track of sectoral trends, and followed the reform process in the US and elsewhere.

Pablo is the Managing Partner at Zuanic & Associates, a firm that recently launched a curated, comprehensive, thoughtful, data-driven research service on the cannabis and psychedelics sectors aimed to institutional investors and corporations. Pablo and the firm are also available for short term consulting and research advisory projects.

Guest Links

https://www.linkedin.com/in/pablo-zuanic-21b5a610
https://zuanicgroup.com/
https://twitter.com/420odysseus

Follow us: Our Links.

At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.

8th Revolution Cannabinoid Playbook is an Industry-leading report covering the entire cannabis supply chain

The Dime is a top 5% most shared global podcast

The Dime is a top 50 Cannabis Podcast

Sign up for our playbook here:

🎥 YouTube:  The Dime

📸 Instagram:  The Dime